{"organizations": [], "uuid": "5bfaa305beaf89a5d82a6133d025d726c31aafd0", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-retrophin-enters-into-future-acqui/brief-retrophin-enters-into-future-acquisition-right-joint-development-agreement-with-censa-pharma-idUSFWN1P00DR", "country": "US", "domain_rank": 408, "title": "BRIEF-Retrophin Enters Into Future Acquisition Right, Joint Development Agreement With Censa Pharma", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-05T16:05:00.000+02:00", "replies_count": 0, "uuid": "5bfaa305beaf89a5d82a6133d025d726c31aafd0"}, "author": "", "url": "https://www.reuters.com/article/brief-retrophin-enters-into-future-acqui/brief-retrophin-enters-into-future-acquisition-right-joint-development-agreement-with-censa-pharma-idUSFWN1P00DR", "ord_in_thread": 0, "title": "BRIEF-Retrophin Enters Into Future Acquisition Right, Joint Development Agreement With Censa Pharma", "locations": [], "entities": {"persons": [{"name": "ri", "sentiment": "negative"}, {"name": "retrophin", "sentiment": "none"}], "locations": [{"name": "censa", "sentiment": "none"}, {"name": "co", "sentiment": "none"}], "organizations": [{"name": "sec", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "joint development agreement with censa pharma reuters", "sentiment": "none"}, {"name": "retrophin inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "January 5, 2018 / 2:05 PM / Updated 11 minutes ago BRIEF-Retrophin Enters Into Future Acquisition Right, Joint Development Agreement With Censa Pharma Reuters Staff 1 Min Read \nJan 5 (Reuters) - Retrophin Inc: \n* RETROPHIN SAYS ON DEC 16, CO ENTERED INTO FUTURE ACQUISITION RIGHT, JOINT DEVELOPMENT AGREEMENT WITH CENSA PHARMA - SEC FILING \n* RETROPHIN SAYS IF CO EXERCISES OPTION TO BUY CENSA, COMPANY WILL HAVE TO PAY $65 MILLION IN UPFRONT CONSIDERATION \n* RETROPHIN - ‍AGREED TO FUND CERTAIN DEVELOPMENT ACTIVITIES OF CENSA‘S CNSA-001 PROGRAM IN AMOUNT EXPECTED TO BE ABOUT $16 MILLION THROUGH PROOF OF CONCEPT​ \n* RETROPHIN - ALSO ‍HAS RIGHT TO ACQUIRE CENSA ON TERMS AND SUBJECT TO CONDITIONS SET FORTH IN A SEPARATE AGREEMENT AND PLAN OF MERGER​ Source text: ( bit.ly/2EZP7YP ) Further company coverage:", "external_links": [], "published": "2018-01-05T16:05:00.000+02:00", "crawled": "2018-01-05T16:22:05.012+02:00", "highlightTitle": ""}